Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report) fell 1.7% during mid-day trading on Thursday . The stock traded as low as $65.00 and last traded at $65.00. 200 shares were traded during trading, a decline of 42% from the average session volume of 344 shares. The stock had previously closed at $66.10.
Bioqual Stock Performance
The company’s fifty day moving average price is $67.09 and its 200-day moving average price is $69.15. The stock has a market cap of $58.11 million, a P/E ratio of -52.85 and a beta of -0.34.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported ($0.76) earnings per share for the quarter. Bioqual had a negative net margin of 1.99% and a negative return on equity of 2.87%. The company had revenue of $11.77 million for the quarter.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
See Also
- Five stocks we like better than Bioqual
- What to Know About Investing in Penny Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Nebius Group: The Rising Star in AI Infrastructure
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
